CX-2 Solution
En vente sur le marché américain (selon le DSLD)
DaVinci Laboratories, food supplement from the US market
CX-2 Solution (DaVinci Laboratories), a food supplement au code-barres 026664237613, is described by its US market label, recorded on 14 December 2023. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label, entered on 14 December 2023. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- DaVinci Laboratories
- Barcode
- 026664237613
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Cellulose, Microcrystalline Cellulose, Leucine, Pharmaceutical Glaze
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Glucosamine Hydrochloride | Other substance | 750 mg |
| Methylsulfonylmethane | Other substance | 500 mg |
| Phellodendron amurense bark extract | Plant | 250 mg |
| Meriva | Other substance | 250 mg |
| Sea Cucumber | Ingredient of animal origin | 150 mg |
| Boswellia serrata Extract | Plant | 150 mg |
| Boswellic Acids | Other substance | 90 mg |
| Quercetin | Other substance | 100 mg |
| N,N-Dimethylglycine Hydrochloride | Other substance | 75 mg |
| Sodium Hyaluronate | Mineral | 20 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: CX-2 Solution
Entered into DSLD on 18 July 2023. Retirée du marché américain le 1 October 2022 (selon le DSLD).- Same quantity, different name: Glucosamine HCl in this version; Glucosamine Hydrochloride on the displayed label (750 mg)
- Same quantity, different name: Curcumin Phytosome in this version; Meriva on the displayed label (250 mg)
- Same quantity, different name: N,N-Dimethylglycine HCl in this version; N,N-Dimethylglycine Hydrochloride on the displayed label (75 mg)
Official label: CX-2 Solution
Entered into DSLD on 22 May 2021. Retirée du marché américain le 17 August 2022 (selon le DSLD).- Same quantity, different name: Glucosamine HCl in this version; Glucosamine Hydrochloride on the displayed label (750 mg)
- Same quantity, different name: N,N-Dimethylglycine HCl in this version; N,N-Dimethylglycine Hydrochloride on the displayed label (75 mg)
Official label: CX-2 Solution
Entered into DSLD on 25 March 2021. Retirée du marché américain le 19 April 2021 (selon le DSLD).- Same quantity, different name: Glucosamine HCl in this version; Glucosamine Hydrochloride on the displayed label (750 mg)
- Same quantity, different name: Curcumin in this version; Meriva on the displayed label (250 mg)
- Same quantity, different name: N,N-Dimethylglycine HCl in this version; N,N-Dimethylglycine Hydrochloride on the displayed label (75 mg)
Official label: CX-2 Solution
Entered into DSLD on 25 June 2013. Retirée du marché américain le 23 December 2020 (selon le DSLD).- Active ingredient added : Curcumin Extract (200 mg)
- Active ingredient added : Curcuminoids (190 mg)
- Active ingredient added : Phellodiendron amurense (250 mg)
- Active ingredient removed : Meriva (250 mg)
- Active ingredient removed : Phellodendron amurense bark extract (250 mg)
- Same quantity, different name: Boswellic Acid in this version; Boswellic Acids on the displayed label (90 mg)
- Same quantity, different name: Glucosamine HCl in this version; Glucosamine Hydrochloride on the displayed label (750 mg)
- Same quantity, different name: DMG HCl in this version; N,N-Dimethylglycine Hydrochloride on the displayed label (75 mg)
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : DaVinci Laboratories